This hypothesis was tested by screening the gene expression profile in wild type DLD-1 colon cancer cells (DLD-1 WT cells) and the isogenic line ablated with both BAX and BAK (DLD-1 BAX–BAK DKO cells) using the human cancer drug resistance PCR array. The gene discussed is BAX; the disease is malignant colon neoplasm.